Immune Thrombocytopenia | Oncology Today with Dr Neil Love: Management of Immune Thrombocytopenia (Faculty Lecture)

Featuring a slide presentation and related discussion from Dr Hanny Al-Samkari, including the following topics: Indications for initiation of treatment for patients with immune thrombocytopenia (ITP) and selection of first-line therapy (0:00) Treatment algorithm for ITP in the second line and beyond (7:47) Role of thrombopoietin receptor agonists and fostamatinib for second- and later-line treatment of ITP (14:21) Novel investigational approaches for the treatment of ITP — efgartigimod, rilzabrutinib and ianalumab (28:24) CME information and select publications